EvenUp
B2B SaaS sold to PI law firms (per-case / seat / usage pricing on AI-drafted demand packages, medical chronologies, case analysis), extending into a labor-substitution 'Pre-Litigation-as-a-Service' offering that pairs its AI with U.S.-based case-management staff; ARR-driven, land-and-expand within firms
Two firmly-grounded priced rounds; valuation roughly doubled in ~12 months. $385M total raised across all rounds. The ~$2B Series E mark is reported as '~$2B+' and not officially confirmed to a precise figure, so the E point is an approximation.
Earnings, margins, COGS & capex
Private growth-stage vertical-AI company. No audited public financials. The disclosed signal is momentum: ARR doubling YoY, case volume ~10,000/week (roughly doubled in the six months before the Oct 2025 raise), 2,000+ firms (incl. ~30% of the Top-100 U.S. PI firms as of the May 2026 PLAAS launch, up from ~20% at the Oct 2025 raise), 200,000+ cases resolved and $14B+ in damages secured to date (up from $10B+ at the Oct 2025 raise). Monetization is per-case/seat SaaS; unit economics gated by variable LLM/compute cost per medical-record-heavy case. Nearly 90% of new sales come from 2025-launched products, indicating fast product-led expansion but also revenue concentration in young, less-proven SKUs.
Revenue trend
Margins
Pressured by per-case LLM/compute cost; improves with model efficiency + pricing power
Growth-stage burn
Cash-consumptive
COGS structure
Primary COGS is variable AI inference/compute for ingesting and analyzing large medical-record and evidence sets per case, plus a human-in-the-loop review/QA layer (attorney-grade output still requires internal + customer-side attorney review). The PLAAS offering adds U.S.-based case-management staff labor. This gives it more variable-cost intensity than classic zero-marginal-cost SaaS.
Capex
Minimal physical capex — software company running on public cloud + third-party foundation-model APIs; spend is opex (cloud/inference, R&D headcount, GTM, PLAAS services staff), not capital equipment.
Latest earnings
n/a
No public guidance. Company narrative targets continued ~2x ARR growth and deeper PI-firm penetration; Series E earmarked for product expansion and the pre-litigation services push.
- Post-money valuation
- ~$2B+ (Oct 2025)
- Total raised
- $385M
- Firms on platform
- 2,000+
- Top-100 PI firm penetration
- ~30% (May 2026; ~20% at Oct 2025 raise)
- Cases/week
- ~10,000
- Cases resolved to date
- 200,000+
- Damages secured to date
- $14B+ (May 2026; $10B+ at Oct 2025 raise)
Growth drivers
- Land-and-expand across the 2,000+ firm base and up the Top-100 PI firm list (~30% penetrated as of mid-2026, up from ~20% at the Oct 2025 raise)
- New 2025 product SKUs (already ~90% of new sales) plus the May 2026 'Pre-Litigation-as-a-Service' move from software into outsourced case-prep labor — expands TAM from tooling to services
- Structural tailwind — ~half of injury cases lack representation and attorneys handle ~100 cases/yr manually — AI drafting compresses cost-to-serve
- Strategic distribution via REV/LexisNexis (RELX) investment — data + channel into the legal-research incumbency
- Category funding momentum for legal AI broadly (Harvey, Supio, Eve) validating buyer budgets
Bull & bear
EvenUp is the emerging system-of-record for AI-native plaintiff PI work in a fragmented, underserved market — compounding a domain data moat while ARR doubles and it expands from tooling into higher-ACV outsourced services.
- Clear category leadership: 2,000+ firms, ~30% of Top-100 PI firms, 200,000+ cases and $14B+ damages secured build a proprietary outcomes dataset competitors can't easily replicate
- ARR ~2x YoY with case volume doubling in six months — genuine product-market fit, not a demo
- Pre-Litigation-as-a-Service reframes the company from seat-license SaaS to labor substitution, multiplying TAM against a $60B+ (~$61B) U.S. PI legal market
- Strategic REV/LexisNexis (RELX) backing gives data, credibility and a distribution channel into the legal incumbency
- Top-tier cap table ($385M raised) funds multi-year expansion without near-term financing pressure
A ~$2B valuation is priced on a growth narrative with no disclosed profitability, thin defensibility against foundation-model commoditization and far-larger-funded rivals, and real product-liability and culture risks.
- Valuation doubled to ~$2B in under a year on undisclosed absolute revenue — multiple compression is severe if ARR growth slows or a down round hits
- Moat is questionable: demand-letter drafting is increasingly a foundation-model capability; Harvey (~$11B), Thomson Reuters/CoCounsel and LexisNexis/RELX can bundle PI features and out-distribute a point solution
- Per-case LLM/compute COGS plus a required human-review layer (and now PLAAS services staff) cap gross margin below classic SaaS
- Liability tail: a hallucinated citation or wrong medical fact in a filed demand invites sanctions and can rapidly erode buyer trust in a reputation-sensitive profession
- Glassdoor/LinkedIn signals of layoffs and culture strain point to execution risk while scaling; revenue concentration in unproven 2025 SKUs and one $4M+ customer adds fragility
What it is worth
Last-priced-round anchor (Series E, Oct 2025) cross-checked against legal-AI comps and a revenue-multiple sanity check on undisclosed ARR
Down round toward ~$1B or below if ARR growth stalls, foundation-model commoditization compresses the app-layer premium, a hallucination/liability event dents trust, or the legal-AI funding climate tightens before profitability.
~$2B holds near-term
if growth stays strong but decelerates toward normalization and margins remain sub-SaaS; valuation grows into itself over 2-3 years rather than re-rating sharply.
~$3B+
if ARR keeps doubling, Pre-Litigation-as-a-Service scales into a services-sized wallet, and EvenUp defends category leadership — supporting a premium growth multiple or a strategic acquisition by a legal-data incumbent (RELX/Thomson Reuters).
~$2B+ post-money from the $150M Series E (Oct 2025), roughly doubling the ~$1B Series D ($135M, Oct 2024). With ARR undisclosed but doubling YoY, the implied revenue multiple is high and rests on sustained growth. Comparable frame: Harvey (~$11B private, ~$190M ARR), Thomson Reuters (TRI) and RELX as public legal-AI proxies. Private, illiquid — no public price; valuation is a negotiated round mark, not a market quote.
SWOT
Strengths
- Category leader in a specific, high-value vertical (plaintiff-side PI), with 2,000+ firms and ~30% of Top-100 PI firms
- Strong momentum signals — ARR ~2x YoY, case volume ~doubled in six months to ~10,000/week
- Deep-pocketed, blue-chip cap table (Bessemer, Lightspeed, Bain Capital Ventures, B Capital, SignalFire, Adams Street, Premji Invest, HarbourVest, Broadlight) + strategic REV/LexisNexis (RELX) investor for data and distribution
- Proprietary workflow + accumulated PI case/outcome data creating a domain-specific data moat vs. horizontal legal-AI tools
- Fast product velocity — ~90% of new sales from 2025-launched products
Weaknesses
- No disclosed absolute revenue or path-to-profit — ~$2B valuation rests on growth-rate narrative, not audited economics
- Variable LLM/compute COGS per medical-record-heavy case caps gross margin vs. classic SaaS
- Human-in-the-loop still required — outputs are drafts needing attorney review, so it is efficiency tooling, not full automation; liability from any hallucinated citation/medical fact sits with the firm
- Reported culture/execution friction and layoffs surfacing in Glassdoor/LinkedIn — talent-retention and scaling risk
- Revenue concentration in young 2025 SKUs and a very large single customer ($4M+ ACV)
Opportunities
- TAM expansion via Pre-Litigation-as-a-Service — moving from software into outsourced case-prep labor is a far larger wallet than seat licenses
- Adjacent expansion beyond PI (mass tort, workers' comp, other plaintiff verticals) and up the case lifecycle into litigation/trial prep
- International plaintiff-bar markets
- Deeper LexisNexis/RELX integration (research + citator + data) as a distribution and defensibility flywheel
- Improving model efficiency lowers per-case COGS, expanding gross margin over time
Threats
- Well-funded direct competitors — Supio, Eve (a16z-backed), ProPlaintiff, and the horizontal giant Harvey (~$11B, Mar 2026) plus incumbents Thomson Reuters (CoCounsel) and LexisNexis/RELX building native PI capabilities
- Foundation-model commoditization — if GPT/Claude-class models plus a thin wrapper replicate demand-letter drafting, the app-layer premium compresses
- Regulatory / malpractice exposure — an AI-drafted demand with a fabricated citation or wrong medical fact could trigger sanctions and a trust backlash across the buyer base
- Insurance-defense-side AI arms race could neutralize the settlement-leverage value prop
- Down-round / funding-winter risk if ARR growth decelerates before profitability
Moats, dependencies & bottlenecks
Moats
Moderate-Strong 200,000+ resolved cases and $14B+ damages give training/benchmarking data specific to PI that horizontal tools lack; durability depends on keeping the data proprietary vs. model commoditization.
Embedded into demand/chronology workflows across 2,000+ firms; sticky but not contractually locked, and rivals target the same wedge.
First-mover mindshare among plaintiff firms; erodes if a far-better-funded horizontal (Harvey, ~$11B) or incumbent (Thomson Reuters, LexisNexis) enters seriously.
Access to legal data + distribution; also a dependency (see below).
Dependencies
Anthropic and similar; private) Core technology / COGS input Product output quality and per-case cost hinge on external LLM APIs; pricing, rate-limit or capability shifts flow straight to margin and roadmap.
Amazon AWS (AMZN) / Microsoft Azure (MSFT) Compute / hosting Standard hyperscaler dependency for inference and data processing.
Revenue concentration Single vertical and a very large ($4M+ ACV) top customer; sensitive to legal-industry AI-adoption pace and any trust setback.
Strategic investor, data + distribution partner Valuable channel and data, but RELX is also a potential competitor via LexisNexis legal-AI products.
Growth-stage burn with no disclosed profitability; future rounds depend on sustained ARR growth and a supportive legal-AI funding climate.
Advantages
- Deep PI-specific product and data vs. horizontal legal-AI generalists
- Largest disclosed footprint in plaintiff PI (2,000+ firms, ~30% of Top-100)
- Best-in-class cap table and $385M war chest
- Fast product velocity converting to sales (~90% of new sales from 2025 SKUs)
- Strategic RELX/LexisNexis relationship for data and distribution
Weaknesses
- No disclosed absolute revenue or profitability; valuation is narrative-driven
- Sub-SaaS gross margin from per-case compute + human review + PLAAS services
- Thin defensibility vs. foundation-model commoditization and far-larger-funded entrants (Harvey ~$11B)
- Product-liability/hallucination exposure in a reputation-critical field
- Reported culture strain, layoffs, and revenue concentration risk
Bottlenecks
- Per-case LLM/compute cost limits gross-margin expansion until models get cheaper or pricing power grows
- Human-in-the-loop review requirement (and PLAAS services staffing) caps the degree of true automation and adds a services-cost layer
- Accuracy/hallucination ceiling in a zero-tolerance liability domain constrains how much attorneys will offload
- Sales cycle and trust-building into risk-averse law firms slow top-of-funnel
- Talent retention amid reported culture/layoff friction while scaling headcount
Top signals & trends
Top signals
Strong investor conviction; also raises the bar for future performance.
Genuine demand momentum.
Incumbent validation + distribution/data — but also signals RELX's own interest in the space.
Bullish (TAM), Neutral-to-cautious (margin) · Expands wallet but adds a services/labor cost layer that can dilute software margins.
Execution/retention risk while scaling.
Product velocity is strong but revenue quality is unproven and concentrated.
Trends
PI legal is a large, manual, fragmented target ripe for AI drafting.
Lowers COGS over time but erodes the app-layer premium as base models replicate drafting.
Positive near-term, Negative competitively · Validates budgets but funds well-capitalized rivals.
EvenUp's pre-litigation services push rides the shift from tools to delivered work.
Sanctions for AI hallucinations raise the accuracy bar and buyer caution.
Ecosystem & competitor graph
Suppliers feed the company; customers pull from it. Line thickness shows the strength of each tie (supply-chain dependency, customer earnings contribution). Hover to isolate a tie.
Foundation-model API provider (private) — core inference dependency and COGS driver.
Foundation-model provider (private) — alternative/complementary LLM supplier.
Cloud compute/hosting for inference and data pipelines.
Cloud/AI infrastructure and OpenAI model access.
Upstream GPU supplier underpinning the inference the product depends on (indirect).
plaintiff-side personal-injury law firms (2,000+, incl. ~30% of Top-100 PI firms) Primarily private firms (e.g., large PI practices like Morgan & Morgan) — the entire revenue base is this single vertical.
Private, horizontal legal-AI leader (~$11B valuation, GIC/Sequoia round Mar 2026; ~$190M ARR) — could extend into PI and out-distribute a point solution.
Public legal-information incumbent with a well-funded legal-AI assistant (CoCounsel), deep firm relationships, and a PI push (Thomson Reuters Ventures backs Supio).
Public legal-data incumbent and EvenUp investor (via REV) — data + AI products make it both partner and potential rival.
Private ($60M Series B Apr 2025, ~$91M raised; Sapphire, Mayfield, Thomson Reuters Ventures); closest PI-specific record-analysis rival, emphasizes human-verified accuracy to curb hallucinations.
Private, a16z-backed legal-AI building multi-stage PI case agents.
Private; focused fast cited demand-letter output for PI teams.
Private practice-management platforms adding AI drafting that could bundle EvenUp's wedge.